Peter Campbell is head of the Cancer, Ageing and Somatic Mutation programme at the the Wellcome Sanger Institute. His research focuses on the use of next-generation sequencing technologies for annotating cancer genomes, and increasingly the acquisition of genetic changes, known as somatic mutations, in normal tissues. He has expertise in the large-scale sequencing of cancer genomes, development of computational tools for the integration and analysis of genomic data sets in cancer and the translation of advances in genomic technologies into improvements in the clinical management of patients with cancer.
His recent work has focused on the patterns of mutation in normal cells, with particular relevance to how the earliest changes of cancer accrue throughout life, how these mutations shape the ageing process and their relevance to diseases other than cancer.
Professional position
- Head, Cancer, Ageing, and Somatic Mutations Programme, Wellcome Sanger Institute, University of Cambridge
Subject groups
-
Cell Biology
Genetics (excluding population genetics)
Awards
-
Darwin Medal
For his pioneering contributions to somatic evolution, including some of the most creative and influential studies of evolution in cancer and normal tissues.
